Parus Finance (Uk) LTD Moderna, Inc. Transaction History

Parus Finance (Uk) LTD

$310 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$101.21 - $166.61 $44,937 - $73,974	444 Added 1.72%	26,328 $3.13 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $101,931 - $137,835	-1,194 Reduced 4.41%	25,884 $2.76 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $21,965 - $32,999	-316 Reduced 1.15%	27,078 $2.69 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $328,179 - $430,980	-3,404 Reduced 11.05%	27,394 $2.83 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $163,648 - $221,691	-1,381 Reduced 4.29%	30,798 $3.74 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $77,597 - $112,695	572 Added 1.81%	32,179 $4.94 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $561,121 - $995,589	4,740 Added 17.64%	31,607 $5.68 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $1.48 Million - $2.43 Million	-12,510 Reduced 31.77%	26,867 $3.18 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $3.52 Million - $5.3 Million	30,010 Added 320.38%	39,377 $5.63 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $416,812 - $774,724	-3,296 Reduced 26.03%	9,367 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $3.44 Million - $5.62 Million	-15,244 Reduced 54.62%	12,663 $3.22 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $10.9 Million - $23.8 Million	-49,163 Reduced 63.79%	27,907 $10.7 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $935,481 - $1.69 Million	7,201 Added 10.31%	77,070 $18.1 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $2.17 Million - $3.69 Million	19,859 Added 39.71%	69,869 $9.15 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $3.29 Million - $8.49 Million	50,010 New	50,010 $5.23 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parus Finance (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parus Finance (Uk) LTD with notifications on news.

Account